Search Results

A histological picture of lung tissue stained purple and pink using H&E stain, showing areas of lung tissue.
Medicine

New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer

MBT Desk
3 min read
KRAS is the most common oncogenic driver in non-squamous cell lung cancer, found to be mutated in 25% to 30% of patients.
A presentation slide titled abstract CT016 and about First-in-Class Werner Helicase Inhibitor.
Biotechnology

Roche’s First-in-Class Werner Helicase Inhibitor Shows Early Promise in Phase I Cancer Trial

MBT Desk
2 min read
This drug works similarly to other DNA damage repair inhibitors, such as PARP inhibitors.
PARP1-selective inhibitor Demonstrates Early Efficacy in Breast Cancers with DNA Repair Defects
Biotechnology

PARP1-selective inhibitor Demonstrates Early Efficacy in Breast Cancers with DNA Repair Defects

MBT Desk
2 min read
Saruparib is a new-generation oral inhibitor selectively targeting PARP1. The improved safety profile can allow for more combinations to bring benefits to patients in earlier disease stages.
ALS is a degenerative disease of the nervous system particularly affecting and harmful to motor neurons. (Representational image: Wikimedia Commons)
Medicine

Pharmacological Inhibitor Protects Nerve Cells in ALS Disease

MBT Desk
3 min read
New Drug Shows Promise in Treating ALS
Combination of inhibitors may suppress tumor growth and prevent relapse in patients with certain cancers, including head and neck squamous cell carcinoma and lung adenocarcinoma. (Representational Image: Unsplash)
Medicine

A Combination of Cancer Inhibitors Shows Success in Slowing Tumor Growth

MBT Desk
3 min read
Cancer Inhibitors (AXL and EGFR) combined hold promise in fighting certain head, neck, and lung cancers
Biomedicine relies upon the use of protein inhibitors based on the assumption that lowering disease-promoting protein levels or activity is generally beneficial when treating cancer.
Biotechnology

Rethinking the Protein Inhibitor Approach to Cancer Therapy

MBT Desk
4 min read
New cell manipulation method that controls metastasis activator protein BACH1 shows inhibiting it sometimes results in further cancer cell invasion; discovery highlighted in Nature Chemical Biology
Read More
logo
Medbound
www.medboundtimes.com